Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

Goodman, Shaun G; Aylward, Philip E; Szarek, Michael; Chumburidze, Vakhtang; Bhatt, Deepak L; Bittner, Vera A; Diaz, Rafael; Edelberg, Jay M; Hanotin, Corinne; Harrington, Robert A; Jukema, J Wouter; Kedev Sasko; Letierce, Alexia; Moryusef, Angele; Pordy, Robert; Ramos López, Gabriel Arturo; Roe, Matthew T; Viigimaa, Margus; White, Harvey D; Zeiher, Andreas M

doi:10.1016/j.jacc.2019.07.015

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

Journal

Journal of the American College of Cardiology

Date Issued

2019

Author(s)

Goodman, Shaun G

Aylward, Philip E

Szarek, Michael

Chumburidze, Vakhtang

Bhatt, Deepak L

Bittner, Vera A

Diaz, Rafael

Edelberg, Jay M

Hanotin, Corinne

Harrington, Robert A

Jukema, J Wouter

Letierce, Alexia

Moryusef, Angele

Pordy, Robert

Ramos López, Gabriel Arturo

Roe, Matthew T

Viigimaa, Margus

White, Harvey D

Zeiher, Andreas M

Steg, Ph Gabriel

Schwartz, Gregory G

DOI

10.1016/j.jacc.2019.07.015

Abstract

Patients with acute coronary syndrome (ACS) and history of coronary artery bypass grafting (CABG) are at high risk for recurrent cardiovascular events and death.